Refractory Chronic Lymphocytic Leukemia
- 1 January 2004
- journal article
- Published by Springer Nature in American Journal of Cancer
- Vol. 3 (3) , 163-178
- https://doi.org/10.2165/00024669-200403030-00003
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemiaCancer, 2003
- Fludarabine in Resistant or Relapsing B-Cell Chronic Lymphocytic LeukemiaThe Spanish GroupExperienceLeukemia & Lymphoma, 1996
- Erythropoietin treatment of anaemia associated with lymphoproliferative disordersEuropean Journal Of Cancer, 1993
- CladribineDrugs, 1993
- PentostatinDrugs, 1993
- Fludarabine in patients with advanced and/or resistant B‐chronic lymphocytic leukemiaEuropean Journal of Haematology, 1993
- Transfection of the CD20 cell surface molecule into ectopic cell types generates a Ca2+ conductance found constitutively in B lymphocytes.The Journal of cell biology, 1993
- Modified vincristine, doxorubicin, and dexamethasone regimen in the treatment of resistant or relapsed chronic lymphocytic leukemia an eastern cooperative oncology group studyCancer, 1993
- Treatment of advanced chronic lymphocytic leukemia by fludarabineAnnals of Hematology, 1991
- Pentostatin in Refractory Chronic Lymphocytic Leukemia: A Phase II Trial of the European Organization for Research and Treatment of CancerJNCI Journal of the National Cancer Institute, 1990